BCM
INSM icon

BlueCrest Capital Management’s Insmed INSM Stock Holding History

BlueCrest Capital Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-20,000
Closed -$416K – 848
2015
Q1 		$416K Buy
+20,000
New +$352K 0.02% 486

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlueCrest Capital Management's INSM Position: Q2 2015 in Review

BlueCrest Capital Management sold out of Insmed (INSM) in Q2 2015, closing a stake of 20,000 shares — an estimated $416K sold.

BlueCrest Capital Management first reported a position in INSM in Q1 2015 and held it in 1 quarter. The position peaked at $416K in Q1 2015. 116 funds tracked by Wall St. Rank hold INSM as of Q2 2015.

  • BlueCrest Capital Management reported no remaining Insmed position as of Q2 2015 after selling out during the quarter.
  • BlueCrest Capital Management sold 20,000 Insmed shares in Q2 2015, an estimated $416K.
  • BlueCrest Capital Management first reported a position in Insmed in Q1 2015 and held it in 1 quarter.
  • BlueCrest Capital Management's Insmed position peaked at $416K in Q1 2015.
  • 116 funds tracked by Wall St. Rank held Insmed as of Q2 2015.

Based on BlueCrest Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.